Bright Pharmaceutical: Plans to repurchase shares worth 10-20 million yuan, has repurchased nearly 3 million yuan.

BoRui Pharmaceutical announced that on September 26, 2025, the board of directors agreed to repurchase shares through centralized bidding trading for the employee stock ownership plan or equity incentives, with an estimated repurchase amount of 10-20 million yuan, with the repurchase period until September 25, 2026. As of October 31, 2025, the company has repurchased a total of 55,880 shares, accounting for 0.0132% of the total share capital, with a repurchase price ranging from 52.96 yuan per share to 54.28 yuan per share, and a total payment of 29.9393 million yuan.